Long-Term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders: An Extension Study of 2 Randomized Clinical Trials
JAMA Dermatol 2021 May 12;[EPub Ahead of Print], JI Silverberg, EL Simpson, A Wollenberg, R Bissonnette, K Kabashima, AM DeLozier, L Sun, T Cardillo, FP Nunes, K ReichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.